Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Autoimmune Disease

PUBLISHER: Grand View Research | PRODUCT CODE: 1679389

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1679389

Celiac Disease Treatment Market Size, Share & Trends Analysis Report By Treatment (Vitamins & Minerals, Gluten Degrading Enzymes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies), By Region, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Celiac Disease Treatment Market Trends:

The global celiac disease treatment market size was estimated at USD 690.2 million in 2024 and is projected to grow at a CAGR of 11.7% from 2025 to 2030. Foremost among these is the escalating prevalence of diagnosed celiac disease cases globally. According to recent estimates, approximately 1 in 100 Americans suffers from celiac disease, although a significant proportion of cases remain undiagnosed. This rise in diagnosed instances, attributed to increased awareness and improved diagnostic capabilities, directly translates into a greater demand for effective treatments and diagnostic methodologies. The market benefits from this increasing patient base, driving pharmaceutical innovation and expanding the need for specialized dietary management.

As public knowledge about celiac disease symptoms and the crucial role of early diagnosis continues to grow, individuals are increasingly proactively seeking medical consultations and testing, thereby contributing to the increased identification of cases. Notably, a 2023 survey by Beyond Celiac revealed that only approximately 50% of Americans know anything about celiac disease or gluten sensitivity, indicating a growing awareness gap that needs to be bridged. However, the expanding gluten-free food industry offers a diverse range of dietary options for individuals managing the disease. The availability of these products plays a significant role in patient adherence to dietary restrictions, thereby improving health outcomes and contributing to market growth.

Improvements in detection methods, such as advancements in point-of-care testing (POCT), have facilitated earlier identification and intervention, leading to quicker and more effective treatment. Government initiatives across numerous nations, including screening programs targeting high-risk demographics, further bolster market development. These proactive measures increase the number of diagnosed cases and provide patients with timely access to diagnostics and treatment options, thereby promoting a more comprehensive and proactive healthcare approach. Notably, various countries have implemented programs to raise awareness about celiac disease and enhance access to diagnostics and treatment, underscoring the commitment to addressing this growing health concern.

Ongoing research into new therapeutic modalities assures novel developments in the treatment of celiac disease in the coming years. The development of anti-inflammatory drugs and therapeutic vaccines is expected to enhance treatment options and expand market opportunities. Furthermore, increasing healthcare expenditure and robust R&D activities, particularly in novel treatment alternatives, are poised to drive market expansion. Key players are increasingly investing in drugs and gluten-free products, indicating an emphasis on improving patient health, driving market penetration, and catering to an expanding consumer base.

Global Celiac Disease Treatment Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global celiac disease treatment market report based on treatment, distribution channel, and region:

  • Treatment Outlook (Revenue, USD Million, 2018 - 2030)
  • Vitamins & Minerals
  • Gluten Degrading Enzymes
  • Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
  • Other Treatments
  • Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other Distribution Channels
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-488-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Treatment
    • 1.2.2. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Celiac Disease Treatment Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
    • 3.3.3. Pipeline Analysis

Chapter 4. Celiac Disease Treatment Market: Treatment Business Analysis

  • 4.1. Treatment Market Share, 2024 & 2030
  • 4.2. Treatment Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Treatment, 2018 to 2030 (USD Million)
  • 4.4. Vitamins & Minerals
    • 4.4.1. Vitamins & Minerals Market, 2018 - 2030 (USD Million)
  • 4.5. Gluten Degrading Enzymes
    • 4.5.1. Gluten Degrading Enzymes Market, 2018 - 2030 (USD Million)
  • 4.6. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others)
    • 4.6.1. Symptomatic Treatment (Anti-inflammatory Drugs, Antihistamines, Others) Market, 2018 - 2030 (USD Million)
  • 4.7. Other Treatments
    • 4.7.1. Other Treatments Market, 2018 - 2030 (USD Million)

Chapter 5. Celiac Disease Treatment Market: Distribution Channel Business Analysis

  • 5.1. Distribution Channel Market Share, 2024 & 2030
  • 5.2. Distribution Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 5.4. Hospital Pharmacies
    • 5.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.5. Retail Pharmacies
    • 5.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 5.6. Other Distribution Channels
    • 5.6.1. Other Distribution Channels Market, 2018 - 2030 (USD Million)

Chapter 6. Celiac Disease Treatment Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Celiac Disease Treatment Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Celiac Disease Treatment Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Teva Pharmaceutical Industries Ltd.
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. Amgen Inc.
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Amneal Pharmaceuticals LLC.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. GLENMARK PHARMACEUTICALS LTD.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Takeda Pharmaceutical Company Limited
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Hikma Pharmaceuticals PLC
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Viatris Inc.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Zydus Pharmaceuticals, Inc.
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Novartis Pharmaceuticals Corporation
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. BioLineRx
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68040-488-7

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global celiac disease treatment market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 5 Global celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 6 North America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 8 North America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 9 U.S. celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 10 U.S. Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 11 Canada celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 12 Canada celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 Mexico celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 14 Mexico celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 15 Europe celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 16 Europe celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 17 Europe celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 18 UK celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 19 UK Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 20 Germany celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 21 Germany celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 22 France celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 23 France Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 24 Italy celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 25 Italy celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 26 Spain celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 27 Spain celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 28 Norway celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 29 Norway Celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 Denmark celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 31 Denmark celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 32 Sweden celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 33 Sweden celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 36 Asia Pacific celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 37 Japan celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 38 Japan celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 39 China celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 40 China celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 41 India celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 42 India celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 43 Australia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 44 Australia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 45 South Korea celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 46 South Korea celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 47 Thailand celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 48 Thailand celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 49 Latin America celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 50 Latin America celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 51 Latin America celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 52 Brazil celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 53 Brazil celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Argentina celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 55 Argentina celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa Celiac disease treatment market, by country, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 58 Middle East & Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 59 South Africa celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 60 South Africa celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 63 UAE celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 64 UAE celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 65 Kuwait celiac disease treatment market, by treatment, 2018 - 2030 (USD Million)
  • Table 66 Kuwait celiac disease treatment market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Celiac disease treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Treatment and distribution channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Celiac disease treatment market dynamics
  • Fig. 12 Celiac disease treatment market: Porter's five forces analysis
  • Fig. 13 Celiac disease treatment market: PESTLE analysis
  • Fig. 14 Celiac disease treatment market: Treatment segment dashboard
  • Fig. 15 Celiac disease treatment market: Treatment market share analysis, 2024 & 2030
  • Fig. 16 Vitamins & minerals market, 2018 - 2030 (USD Million)
  • Fig. 17 Gluten degrading enzymes market, 2018 - 2030 (USD Million)
  • Fig. 18 Symptomatic treatment (anti-inflammatory drugs, antihistamines, others) market, 2018 - 2030 (USD Million)
  • Fig. 19 Other treatments market, 2018 - 2030 (USD Million)
  • Fig. 20 Celiac disease treatment market: Distribution channel segment dashboard
  • Fig. 21 Celiac disease treatment market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 22 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 23 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 24 Other distribution channels market, 2018 - 2030 (USD Million)
  • Fig. 25 Celiac disease treatment market revenue, by region
  • Fig. 26 Regional marketplace: Key takeaways
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 North America celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. country dynamics
  • Fig. 30 U.S. celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 31 Canada country dynamics
  • Fig. 32 Canada celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico country dynamics
  • Fig. 34 Mexico celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 35 Europe celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 36 UK country dynamics
  • Fig. 37 UK celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany country dynamics
  • Fig. 39 Germany celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 40 France country dynamics
  • Fig. 41 France celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 42 Italy country dynamics
  • Fig. 43 Italy celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 44 Spain country dynamics
  • Fig. 45 Spain celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 46 Norway country dynamics
  • Fig. 47 Norway celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden country dynamics
  • Fig. 49 Sweden celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark country dynamics
  • Fig. 51 Denmark celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 52 Asia Pacific celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 53 Japan country dynamics
  • Fig. 54 Japan celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 55 China country dynamics
  • Fig. 56 China celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 57 India country dynamics
  • Fig. 58 India celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia country dynamics
  • Fig. 60 Australia celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea country dynamics
  • Fig. 62 South Korea celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 63 Thailand country dynamics
  • Fig. 64 Thailand celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 65 Latin America celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 66 Brazil country dynamics
  • Fig. 67 Brazil celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 68 Argentina country dynamics
  • Fig. 69 Argentina celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 70 MEA celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 71 South Africa country dynamics
  • Fig. 72 South Africa celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 73 Saudi Arabia country dynamics
  • Fig. 74 Saudi Arabia celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 75 UAE country dynamics
  • Fig. 76 UAE celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 77 Kuwait country dynamics
  • Fig. 78 Kuwait celiac disease treatment market, 2018 - 2030 (USD Million)
  • Fig. 79 Company categorization
  • Fig. 80 Company market position analysis
  • Fig. 81 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!